Research indicates that COPD-related inflammation extends beyond the lungs, resulting in systematic effects as evidenced by an elevation of inflammatory markers such as C-reactive protein (CRP), interleukin (IL)-6, and tumor necrosis factor (TNF)-alphas [14]. The gene discussed is CRP; the disease is chronic obstructive pulmonary disease.